Cargando…

Anakinra for patients with COVID-19

Detalles Bibliográficos
Autores principales:	Maoujoud, Omar, Asserraji, Mohammed, Ahid, Samir, Belarbi, Marouane, Zemraoui, Nadir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316448/ https://www.ncbi.nlm.nih.gov/pubmed/32835237 http://dx.doi.org/10.1016/S2665-9913(20)30177-6

Ejemplares similares

Profil épidémiologique de l'insuffisance rénale terminale à l'hôpital Militaire de Rabat, Maroc
por: Asserraji, Mohammed, et al.
Publicado: (2015)

Tuberculosis in Hemodialysis: Catch me if you can
por: Asserraji, Mohammed, et al.
Publicado: (2022)

The Coronavirus Disease 2019 (COVID-19) Pandemic in Africa: What Can We Expect?
por: Maoujoud, Omar, et al.
Publicado: (2020)

The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients
por: Maoujoud, Omar, et al.
Publicado: (2016)

The Cost-Effectiveness of Continuous Erythropoiesis Receptor Activator Once Monthly versus Epoetin Thrice Weekly for Anaemia Management in Chronic Haemodialysis Patients
por: Maoujoud, Omar, et al.
Publicado: (2015)

Late Care in Marathon Runs Leading to Exertional Heat Stroke with Multiple Organ Failure
por: Asserraji, Mohammed, et al.
Publicado: (2014)

Anakinra for patients with COVID-19
por: Valette, Xavier, et al.
Publicado: (2020)

Anakinra for patients with COVID-19
por: Martin-Silva, Nicolas, et al.
Publicado: (2020)

Effect of anakinra in COVID-19
por: Kooistra, Emma J, et al.
Publicado: (2020)

Anakinra for patients with COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Anakinra in COVID-19: important considerations for clinical trials
por: King, Andrew, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Laine, Marc, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Khan, Adil Rashid, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Khan, Naim Akhtar
Publicado: (2020)

Anakinra for the prophylaxis of venous thromboembolism in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2023)

Current evidence on the use of anakinra in COVID-19
por: Khani, Elnaz, et al.
Publicado: (2022)

Anakinra: a silver lining in COVID-19?
por: Gupta, Rahul
Publicado: (2020)

Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Cytokine storm and use of anakinra in a patient with COVID-19
por: Nemchand, Priyanka, et al.
Publicado: (2020)

Anakinra in COVID-19: A step closer to the cure
por: Barkas, Fotios, et al.
Publicado: (2022)

Anakinra versus Baricitinib: Different Strategies for Patients Hospitalized with COVID-19 †
por: García-García, José A, et al.
Publicado: (2021)

Anakinra for severe forms of COVID-19 – Authors' reply
por: Hayem, Gilles, et al.
Publicado: (2020)

EMA assessing safety of anakinra in adults with COVID-19
Publicado: (2021)

Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
por: Gupta, Rahul
Publicado: (2022)

Jaundice in a patient treated with Anakinra in a context of Covid-19
por: Tarhini, H., et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on digestive cancer staging, a case series
por: Mouni, Omar, et al.
Publicado: (2022)

Anakinra for severe forms of COVID-19: a cohort study
por: Huet, Thomas, et al.
Publicado: (2020)

Evaluation of anakinra in the management of patients with COVID-19 infection: A randomized clinical trial
por: Elmekaty, Eman Zeyad I., et al.
Publicado: (2023)

Evaluation of the effects of anakinra treatment on clinic and laboratory results in patients with COVID-19
por: Siyer, Ozge, et al.
Publicado: (2023)

Use of anakinra in severe COVID-19: A case report
por: Filocamo, Giovanni, et al.
Publicado: (2020)

Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis
por: Dimopoulos, George, et al.
Publicado: (2020)

Anakinra for the treatment of COVID-19 patients: a systematic review and meta-analysis
por: Dahms, Karolina, et al.
Publicado: (2023)

Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab
por: Langer-Gould, Annette, et al.
Publicado: (2020)

Proposal for the use of anakinra in acute respiratory distress secondary to COVID-19()
por: Muñoz-Jiménez, Alejandro, et al.
Publicado: (2021)

Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies.
por: Pasin, Laura, et al.
Publicado: (2021)

Patients diagnosed with COVID-19 and treated with anakinra: a real-world study in the USA
por: Rich, Carly, et al.
Publicado: (2021)

Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report
por: Karadeniz, Hazan, et al.
Publicado: (2020)

An open label trial of anakinra to prevent respiratory failure in COVID-19
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2021)

Anakinra or tocilizumab for prevention of COVID-19 death? A big dilemma
por: Patoulias, Dimitrios, et al.
Publicado: (2021)

Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study
por: Kooistra, Emma J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p5v3o2dcsljqpamih7h031igpu